Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

“The real stroke of brilliance is the notion that you make the cell younger, and then it would be more resilient to injury,” ...

WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy ...

He noticed that people with optic neuritis, a common vision problem in people with MS, had a temporary worsening of their vision when they exercised. Initially, Uhthoff believed exercise itself was ...

Patients on semaglutide (Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) compared to people not taking the drug ...

NAION causes sudden vision loss in one eye due to damaged optic nerves MONDAY, Feb. 24, 2025 (HealthDay News) -- People taking the weight-loss drug semaglutide could be at a slightly increased risk ...

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says. Patients on ...

MONDAY, Feb. 24, 2025 (HealthDay News) -- People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve ...